Back to Newsroom

Axovant Sciences to Present at the Baird 2016 Global Healthcare Conference

HAMILTON, Bermuda, Aug. 31, 2016 /PRNewswire/ — Axovant Sciences Ltd. (NYSE: AXON), a leading clinical-stage biopharmaceutical company focused on the treatment of dementia, today announced that the company will be presenting at the Baird 2016 Global Healthcare Conference on September 7 at 10:50 a.m. EDT.

A simultaneous webcast can be accessed by visiting the Investors section of www.axovant.com  and selecting Events and Presentations. A replay will be available for 30 days following the conference.

Click here to read the full release